Nov. 29, 2021

Formlabs Expands Healthcare Offering with Two New Biocompatible Resins: BioMed White and BioMed Black

These new BioMed resins will diversify the medical resins available to the healthcare community, enabling researchers, surgeons, radiologists, and beyond to provide patients with personalized, precision healthcare.

Nov. 29, 2021 –  

SOMERVILLE, MA - November 29, 2020 – Formlabs, the leading 3D printing company, announced today the development of two new biocompatible materials to be shown for the first time at RSNA 2021, BioMed White Resin and BioMed Black Resin, designed for applications where opaque materials are preferred for functionality or aesthetic quality. Formlabs is dedicated to providing its users with a vast array of materials, and these two upcoming resins further reinforce Formlabs’ commitment to developing new medical grade materials and expanding access to point-of-care manufacturing for healthcare professionals. 


“The value of 3D printing within the healthcare industry cannot be understated,” said Gaurav Manchanda, director of medical market development at Formlabs. “The 3D printing applications in healthcare are vast, from improving patient education through more accurate, real-time modeling, to supporting a more personalized approach to medical devices to better outcomes in the operating room with 3D printed surgical guides. These applications each require materials that are both effective and safe for medical uses. The addition of these resins to Formlabs’ materials library will allow for greater flexibility in design and function and can be used in a variety of applications ranging from medical device manufacturing, biopharmaceutical processing, and consumer goods such as medical device components, wearables, and custom dental appliances.”


Formlabs BioMed Resins are acclaimed for their high performance, sterilization compatibility, and long term stability. These new biocompatible materials will be USP Class VI certified and will  provide premium aesthetics that enable superior patient outcomes by providing access to improved ergonomics through fast medical device iterations, reliable surgical planning, and custom tools for ground-breaking healthcare research. Formlabs is committed to expanding its material library to further eliminate barriers and support further innovation of medical practices that benefit both providers and patients.


“The expanding library of materials from Formlabs has been extremely helpful just to be able to have different qualities of materials for our medical simulations,” says Dr. David Zopf, MD, University of Michigan.

About Formlabs

Formlabs is expanding access to digital fabrication, so anyone can make anything. Headquartered in Somerville, Massachusetts with offices in Germany, Japan, China, Singapore, Hungary, and North Carolina, Formlabs is the professional 3D printer of choice for engineers, designers, manufacturers, and decision makers around the globe. Formlabs products include the Form 3, Form 3B, Form 3L, and Form 3BL powered by an advanced form of stereolithography (SLA) called Low Force Stereolithography (LFS)™ 3D printing, Form Wash and Form Cure post-processing solutions, Fuse 1 SLS 3D printer, and Form Cell manufacturing solution. Through its Factory Solutions offering for industrial users, Formlabs provides the factories of tomorrow with the flexibility and versatility needed for demanding, evolving industrial applications. Formlabs also develops its own suite of high-performance materials that continue to push the boundaries for 3D printing, as well as best-in-class 3D printing software. For more information visit

Formlabs Media Contact

Chelsea Higgins

BIGfish Communications for Formlabs

[email protected]